# François‐Clément Bidard

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francois-clement-bidard/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,808 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 66 |
| i10-index | 193 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5005286764 |
| ORCID iD | https://orcid.org/0000-0001-5932-8949 |
| Works | 546 |

## Researcher papers

- [Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial](https://scholariq.org/papers/elacestrant-oral-selective-estrogen-receptor-degrader-versus-standard-endocrine/)
- [ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group](https://scholariq.org/papers/esmo-recommendations-on-the-use-of-circulating-tumour-dna-assays-for-patients/)
- [Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer](https://scholariq.org/papers/pooled-analysis-of-the-prognostic-relevance-of-circulating-tumor-cells-in/)
- [Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/switch-to-fulvestrant-and-palbociclib-versus-no-switch-in-advanced-breast-cancer/)
- [Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis](https://scholariq.org/papers/circulating-tumor-cells-in-breast-cancer-patients-treated-by-neoadjuvant/)
- [Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types](https://scholariq.org/papers/circulating-tumor-dna-as-a-non-invasive-substitute-to-metastasis-biopsy-for/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.